| Acquired by | Luminex |
| Price | $34M |
| Date | 6/11 |
| Terms | Cash |
| Website | eragen.com |
| Category | BioTech |
| Phone | 608-662-9000 |
| Employees | |
| Founded | 1994 |
| Description | Molecular Reagent Products |
| TOTAL | $12M |
| VENTURE FUNDING TOTAL | $12M |
| Series A, 1/06 First Analysis Prolog Ventures Stonehenge Capital Novartis Venture Funds | $12M |
EraGen Biosciences, Inc., a biotechnology company, develops, manufactures, and markets molecular reagent products and software for research and clinical testing markets. The company offers molecular diagnostic assays for the early detection and monitoring of cancer, genetic, and infectious diseases, as well as for genetic-based conditions. Its products include molecular diagnostic tests, analyte specific reagents, in vitro diagnostic reagents, and research use only reagents; MultiCode-PLx Analysis Software that allows users to create customized templates for plate and assay layouts; and MultiCode-RTx Analysis Software, which enables users to create templates for quantitative and qualitative analyses. The company serves clinical laboratories and medical researchers. It sells its products through distributors in the United States and Canada. The company was founded as Sulfonics, Inc. in 1994 and changed its name to EraGen Biosciences, Inc. in 1999. EraGen Biosciences, Inc. is based in Madison, Wisconsin.
